Oppenheimer & Co. Inc. Acquires 11,145 Shares of PACS Group, Inc. $PACS

Oppenheimer & Co. Inc. bought a new position in shares of PACS Group, Inc. (NYSE:PACS) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 11,145 shares of the company’s stock, valued at approximately $463,000.

A number of other institutional investors also recently bought and sold shares of the company. Nisa Investment Advisors LLC increased its position in shares of PACS Group by 11.0% in the third quarter. Nisa Investment Advisors LLC now owns 2,327 shares of the company’s stock valued at $97,000 after buying an additional 230 shares in the last quarter. Financial Management Professionals Inc. raised its stake in shares of PACS Group by 54.9% during the 2nd quarter. Financial Management Professionals Inc. now owns 663 shares of the company’s stock worth $28,000 after buying an additional 235 shares during the last quarter. Toth Financial Advisory Corp raised its stake in shares of PACS Group by 87.5% during the 3rd quarter. Toth Financial Advisory Corp now owns 1,500 shares of the company’s stock worth $62,000 after buying an additional 700 shares during the last quarter. Peterson Wealth Services raised its stake in shares of PACS Group by 1.6% during the 1st quarter. Peterson Wealth Services now owns 53,672 shares of the company’s stock worth $1,724,000 after buying an additional 854 shares during the last quarter. Finally, GK Wealth Management LLC purchased a new stake in shares of PACS Group in the 3rd quarter worth about $41,000.

PACS Group Trading Down 0.5%

Shares of PACS Group stock opened at $50.03 on Friday. PACS Group, Inc. has a fifty-two week low of $10.31 and a fifty-two week high of $51.68. The firm has a market cap of $7.94 billion, a PE ratio of 22.95, a P/E/G ratio of 1.57 and a beta of -0.14. The business’s fifty day moving average is $44.53 and its two-hundred day moving average is $39.96. The company has a quick ratio of 0.91, a current ratio of 0.80 and a debt-to-equity ratio of 0.22.

PACS Group (NYSE:PACS) last announced its quarterly earnings data on Tuesday, November 3rd. The company reported $0.63 EPS for the quarter, beating analysts’ consensus estimates of $0.58 by $0.05. The business had revenue of $1.50 billion during the quarter, compared to the consensus estimate of $1.46 billion. PACS Group had a return on equity of 31.98% and a net margin of 4.87%. Analysts anticipate that PACS Group, Inc. will post 2.13 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on PACS. Truist Financial reissued a “buy” rating and issued a $65.00 price objective (up from $62.00) on shares of PACS Group in a research note on Thursday. Oppenheimer lifted their target price on shares of PACS Group from $48.00 to $57.00 and gave the stock an “outperform” rating in a research report on Monday, August 10th. Wall Street Zen downgraded shares of PACS Group from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 8th. Zacks Research downgraded shares of PACS Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday, September 9th. Finally, Stephens increased their price target on shares of PACS Group from $60.00 to $64.00 and gave the company an “overweight” rating in a research report on Thursday. Six investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $61.33.

Insiders Place Their Bets

In other PACS Group news, Director Mark Hancock sold 186,696 shares of PACS Group stock in a transaction dated Wednesday, November 4th. The stock was sold at an average price of $50.45, for a total value of $9,418,813.20. Following the completion of the sale, the director owned 53,318,884 shares in the company, valued at $2,689,937,697.80. The trade was a 0.35% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jason Murray sold 167,434 shares of PACS Group stock in a transaction dated Wednesday, November 4th. The shares were sold at an average price of $50.24, for a total value of $8,411,884.16. Following the completion of the sale, the chief executive officer owned 53,954,101 shares of the company’s stock, valued at $2,710,654,034.24. This trade represents a 0.31% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 1,762,431 shares of company stock valued at $80,686,053. Insiders own 70.10% of the company’s stock.

Key PACS Group News

Here are the key news stories impacting PACS Group this week:

• Positive Sentiment: Third-quarter EPS of $0.63 topped estimates of $0.58, while revenue of $1.50 billion exceeded the $1.46 billion consensus. Adjusted EBITDA reportedly rose 33.6%, reinforcing evidence of operating growth. PACS Group, Inc. Reports Third Quarter 2026 Results PACS Group Q3 2026: EBITDA Surges 33.6%
• Positive Sentiment: PACS raised its 2026 revenue outlook to $5.95 billion–$6.05 billion and adjusted EBITDA guidance to $685 million–$695 million. The company also highlighted acquisitions in Florida and Texas and facility occupancy around 90%, supporting its expansion story. PACS raises 2026 outlook PACS acquisitions and Q3 results
• Positive Sentiment: Truist reaffirmed its Buy rating and raised its target to $65 from $62; Stephens raised its target to $64 from $60 and assigned an Overweight rating. Higher targets signal continued analyst confidence in potential upside. Truist analyst ratings Stephens analyst ratings
• Negative Sentiment: The CEO, a director, and the chief accounting officer reported share sales. These could weigh slightly on sentiment, but the trades were made under pre-arranged Rule 10b5-1 plans, and the CEO and director retained large holdings. PACS insider transactions

PACS Group Profile

PACS Group, Inc is a U.S.-based healthcare services company that owns and operates post-acute care facilities. Its platform focuses primarily on skilled nursing and transitional care, serving patients who require rehabilitation, recovery support, long-term care, and other services following hospitalization or acute medical treatment.

The company’s operations also include assisted living, independent living, and behavioral health services in select locations. Through its facilities and related healthcare capabilities, PACS Group provides services such as nursing care, physical and occupational therapy, speech therapy, medical treatment, and support for patients with complex or extended care needs.

Founded in 2013 and headquartered in Farmington, Utah, PACS Group serves communities across multiple U.S.